Skip to main content

Blavatnik Len's Form 4 filing

Upstream Bio, Inc.UPB · filed Oct 17, 2024

Accession no.
0000950170-24-115295
Filed
Oct 17, 2024, 4:05 PM ET
Trade date
Oct 15, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $20.0M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Blavatnik LenCIK 000132662810% Owner
Access Industries Holdings LLCCIK 000139129710% Owner
Access Industries Management, LLCCIK 000150822610% Owner
AI Biotechnology LLCCIK 000194267010% Owner
AI Upstream LLCCIK 000203990710% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 15, 2024Common StockPPurchaseAcquired+1,175,000$17.00+$19,975,0001,175,000Direct
Oct 15, 2024Common StockCConversionAcquired+3,147,000–F1–4,322,000Direct
Oct 15, 2024Common StockCConversionAcquired+1,172,410–F1–5,494,410Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 15, 2024Common StockCConversionDisposed−3,147,000–F1–0Direct
Oct 15, 2024Common StockCConversionDisposed−1,172,410–F1–0Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the "Preferred Stock") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)